Phosphate hemofiltration replacement solution(Chengdu Qingshan Likang Pharmaceutical)

磷酸盐血滤置换液(成都青山利康药业)

Report date: 2026/03/19 20:00:18

Base Information

Drug NamePhosphate hemofiltration replacement solution(Chengdu Qingshan Likang Pharmaceutical)
Drug Alias NameA-1805A1805
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsKidney Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A